These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 27574129)

  • 1. Iodine regulates G2/M progression induced by CCL21/CCR7 interaction in primary cultures of papillary thyroid cancer cells with RET/PTC expression.
    Zhang YY; Liu ZB; Ye XG; Ren WM
    Mol Med Rep; 2016 Oct; 14(4):3941-6. PubMed ID: 27574129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL21/CCR7 promotes G2/M phase progression via the ERK pathway in human non-small cell lung cancer cells.
    Xu Y; Liu L; Qiu X; Jiang L; Huang B; Li H; Li Z; Luo W; Wang E
    PLoS One; 2011; 6(6):e21119. PubMed ID: 21698152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High iodine concentration attenuates RET/PTC3 oncogene activation in thyroid follicular cells.
    Fiore AP; Fuziwara CS; Kimura ET
    Thyroid; 2009 Nov; 19(11):1249-56. PubMed ID: 19725779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and function of the chemokine receptor CCR7 in thyroid carcinomas.
    Sancho M; Vieira JM; Casalou C; Mesquita M; Pereira T; Cavaco BM; Dias S; Leite V
    J Endocrinol; 2006 Oct; 191(1):229-38. PubMed ID: 17065406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway.
    Zhong G; Chen L; Yin R; Qu Y; Bao Y; Xiao Q; Zhang Z; Shen Y; Li C; Xu Y; Zou Z; Tian H
    Mol Med Rep; 2017 Jun; 15(6):4100-4108. PubMed ID: 28487957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The correlation between BRAF mutations, RET/PTC rearrangements and platelet-derived growth factor B expression in papillary thyroid carcinomas].
    Wang P; Wang YG; Zhao WJ; Fu YD; Wang L; Wang F; Zhao SH
    Zhonghua Nei Ke Za Zhi; 2012 Dec; 51(12):987-91. PubMed ID: 23327964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
    Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
    Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL21/CCR7 prevents apoptosis via the ERK pathway in human non-small cell lung cancer cells.
    Xu Y; Liu L; Qiu X; Liu Z; Li H; Li Z; Luo W; Wang E
    PLoS One; 2012; 7(3):e33262. PubMed ID: 22438908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse sclerosing variant of papillary thyroid carcinoma: major genetic alterations and prognostic implications.
    Joung JY; Kim TH; Jeong DJ; Park SM; Cho YY; Jang HW; Jung YY; Oh YL; Yim HS; Kim YL; Chung JH; Ki CS; Kim SW
    Histopathology; 2016 Jul; 69(1):45-53. PubMed ID: 26568156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RET/PTC Rearrangements Are Associated with Elevated Postoperative TSH Levels and Multifocal Lesions in Papillary Thyroid Cancer without Concomitant Thyroid Benign Disease.
    Su X; He C; Ma J; Tang T; Zhang X; Ye Z; Long Y; Shao Q; Shao J; Yang A
    PLoS One; 2016; 11(11):e0165596. PubMed ID: 27802347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL21/CCR7 interaction promotes cellular migration and invasion via modulation of the MEK/ERK1/2 signaling pathway and correlates with lymphatic metastatic spread and poor prognosis in urinary bladder cancer.
    Xiong Y; Huang F; Li X; Chen Z; Feng D; Jiang H; Chen W; Zhang X
    Int J Oncol; 2017 Jul; 51(1):75-90. PubMed ID: 28534984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.
    Tutunea-Fatan E; Majumder M; Xin X; Lala PK
    Mol Cancer; 2015 Feb; 14():35. PubMed ID: 25744065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dose-Response Dependences for Frequency of RET/PTC Gene Rearrangements in Papillary Thyroid Carcinoma after Irradiation. Simple Pooling Analysis of Molecular Epidemiological Data].
    Koterov AN; Ushenkova LN; Biryukov AP
    Radiats Biol Radioecol; 2016; 56(1):5-25. PubMed ID: 27245001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
    Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
    PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma.
    Romitti M; Wajner SM; Ceolin L; Ferreira CV; Ribeiro RV; Rohenkohl HC; Weber Sde S; Lopez PL; Fuziwara CS; Kimura ET; Maia AL
    Endocr Relat Cancer; 2016 Mar; 23(3):135-46. PubMed ID: 26825960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements.
    Mechler C; Bounacer A; Suarez H; Saint Frison M; Magois C; Aillet G; Gaulier A
    Br J Cancer; 2001 Dec; 85(12):1831-7. PubMed ID: 11747322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential responses of human papillary thyroid cancer cell lines carrying the RET/PTC1 rearrangement or a BRAF mutation to MEK1/2 inhibitors.
    Henderson YC; Fredrick MJ; Clayman GL
    Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):810-5. PubMed ID: 17709622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma.
    Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of signal transducer and activator of transcription 3 by oncogenic RET/PTC (rearranged in transformation/papillary thyroid carcinoma) tyrosine kinase: roles in specific gene regulation and cellular transformation.
    Hwang JH; Kim DW; Suh JM; Kim H; Song JH; Hwang ES; Park KC; Chung HK; Kim JM; Lee TH; Yu DY; Shong M
    Mol Endocrinol; 2003 Jun; 17(6):1155-66. PubMed ID: 12637586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of RET/PTC1 and RET/PTC3 gene rearrangements in Chennai population and its correlation with clinical parameters.
    Rao PJ; Vardhini NV; Parvathi MV; Murthy PB; Sudhakar G
    Tumour Biol; 2014 Oct; 35(10):9539-48. PubMed ID: 24957039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.